Alpha-Lipoic Acid and Co-Prescribing for Female Fertility

Optimising female fertility often involves addressing both egg quality and metabolic health. Key nutrients can support this process. Alpha-lipoic acid (ALA) is a nutrient that plays an important role in oxidative metabolism, mitochondrial function and glucose metabolism.¹ By reducing oxidative stress and improving insulin sensitivity, ALA emerges as a particularly promising supplement for supporting female fertility and enhancing reproductive outcomes.

Nutritional Prescribing for Optimising Female Fertility

In clinical practice, specific nutrients are often prescribed to enhance female fertility by targeting key physiological pathways that influence egg quality, ovulation, embryo development, and overall reproductive health. The following categories outline these targets and the nutritional supplements most commonly used to support them.

Oxidative stress, mitochondrial function, ovarian support, and egg quality: coenzyme Q10 (CoQ10)/ubiquinol^2,3 (particularly in women with diminished ovarian reserve⁴ or age-related decline)⁵ and L-carnitine⁶
Insulin signalling and ovulation regularity, especially relevant for women with PCOS: myo-inositol,^7,8 N-acetylcysteine (NAC)^9-12 and lifestyle interventions that improve insulin sensitivity (diet, sleep, exercise, weight management, and stress management)¹³
Early embryo development (preconception): active folate (5-MTHF),¹⁴ as is featured in high quality prenatal multivitamin and mineral formulas; alongside other important nutrients for foetal neurodevelopment, such as docosahexaenoic acid (DHA),¹⁵ choline,^16,17 iodine,^18-20 and iron²¹
Inflammation and overall reproductive environment: omega-3 fatty acids^22-24
Reproductive microbiome, particularly related to successful implantation: probiotics^25,26

Researchers have found that co-prescribing ALA (800 mg/day) and myo-inositol (2 g/day) can improve reproductive outcomes and/or insulin levels in PCOS²⁷ and non-PCOS overweight/obese women undergoing IVF,²⁸ and reduce oxidative stress in the oocyte environment in infertile obese women.²⁹ ALA has also been trialled alongside metformin at a higher dose (1800 mg/day) to improve embryo quality in infertile women with PCOS,³⁰ and in combination with vaginal progesterone at a lower dose (600 mg/day) in women with threatened miscarriage associated with subchorionic haematoma.³¹

It is generally recommended to allow at least three months before actively trying to conceive to address any hormonal and nutritional imbalances in both female and male partners. The same principle applies to women preparing for an IVF cycle, as this timeframe can help optimise ovarian stimulation, egg retrieval and embryo transfer outcomes.³²

A Note on Safety

As a general guideline, be conservative and exercise caution with supplementation during ovarian stimulation in IVF, as research is limited. Advise patients to stick to safe baseline nutrients during this time.

ALA is considered generally safe in pregnancy. ALA is used both as oral and intravenous treatments during pregnancy, particularly to prevent miscarriage and preterm delivery.^33-35 However, avoid high doses of ALA (rare cases of toxicity)^36-40and monitor for signs of insulin autoimmune syndrome (IAS) [rare].^41-49

Some herbs may be used in the lead-up to conception, such as Vitex agnus-castus (Chaste Tree) for menstrual irregularities, luteal phase support (correcting a relative progesterone deficiency) and hyperprolactinaemia.⁵⁰ However, safety and interaction data is limited, and one case reports ovarian hyperstimulation attributed to the use of Chaste Tree in a patient undergoing IVF treatment.⁵¹ Discontinuing herbs prior to IVF treatments/fertility drugs is advised, since their hormonal effects could interfere with controlled ovarian stimulation and clinical monitoring.

Separate to IVF treatment, if Chaste Tree had been used prior to conception, it may be best to continue its use through the early stages of pregnancy then slowly withdraw. Consider monitoring progesterone levels while doing so.⁵²

As with any treatment, individual assessment is important and should be personalised for the patient and underlying factors, including the following:^53-55

Advanced age
Diminished ovarian reserve
Ovulatory disorders (PCOS)
Tubal and uterine factors (endometriosis and uterine fibroids)
Pelvic surgery
Genetic factors
Hypothyroidism
Hyperprolactinaemia
Autoimmune conditions
Male factor infertility
Diabetes
Obesity
Smoking
Excessive alcohol
Endocrine-disrupting chemicals (EDCs)
Stress
Certain medications

*For further guidance, please contact Clinical Support at clinicalsupport@integria.com.

Want to learn more? Head to practitioner.integria.com to explore our library of resources available on ALA, prenatal multivitamin and mineral formulas, and herbs to support female fertility.

References

1. Braun L, Cohen M. Herbs & natural supplements, volume 2: an evidence-based guide. 4th ed. Sydney: Churchill Livingstone; 2015.

2. Jiang Y, Han Y, Qiao P, Ren F. Exploring the protective effects of coenzyme Q10 on female fertility. Front Cell Dev Biol. 2025 Aug;13:1633166. DOI: 10.3389/fcell.2025.1633166

3. Florou P, Anagnostis P, Theocharis P, Chourdakis M, Goulis DG. Does coenzyme Q10 supplementation improve fertility outcomes in women undergoing assisted reproductive technology procedures? A systematic review and meta-analysis of randomized-controlled trials. J Assist Reprod Genet. 2020 Oct;37(10):2377-2387. DOI: 10.1007/s10815-020-01906-3

4. Xu Y, Nisenblat V, Lu C, Li R, Qiao J, Zhen X, et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. Reprod Biol Endocrinol. 2018 Mar;16(1):29. DOI: 10.1186/s12958-018-0343-0

5. Derbyshire EJ, Ostojic SM, Alahmar AT. Ubiquinol in fertility and reproduction: a conditionally essential nutrient for critical early-life stages. Nutrients. 2026 Jan;18(1):156. DOI: 10.3390/nu18010156

6. Agarwal A, Sengupta P, Durairajanayagam D. Role of L-carnitine in female infertility. Reprod Biol Endocrinol. 2018 Jan;16(1):5. DOI: 10.1186/s12958-018-0323-4

7. Gambioli R, Forte G, Buzzaccarini G, Unfer V, Laganà AS. Myo-inositol as a key supporter of fertility and physiological gestation. Pharmaceuticals (Basel). 2021 May;14(6):504. DOI: 10.3390/ph14060504

8. Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017 Nov;6(8):647-658. DOI: 10.1530/EC-17-0243

9. Viña I, Viña JR, Carranza M, Mariscal G. Efficacy of N-acetylcysteine in polycystic ovary syndrome: systematic review and meta-analysis. Nutrients. 2025 Jan;17(2):284. DOI: 10.3390/nu17020284

10. Fang YQ, Ding H, Li T, Zhao XJ, Luo D, Liu Y, et al. N-acetylcysteine supplementation improves endocrine-metabolism profiles and ovulation induction efficacy in polycystic ovary syndrome. J Ovarian Res. 2024 Oct;17(1):205. DOI: 10.1186/s13048-024-01528-8

11. Thakker D, Raval A, Patel I, Walia R. N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Obstet Gynecol Int. 2015;2015:817849. DOI: 10.1155/2015/817849

12. Fulghesu AM, Ciampelli M, Muzj G, Belosi C, Selvaggi L, Ayala GF, et al. N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril. 2002 Jun;77(6):1128-1135. DOI: 10.1016/s0015-0282(02)03133-3

13. Healthline. Top natural ways to improve your insulin sensitivity [Internet]. San Francisco: Healthline; 2025 [cited 2026 Feb 20]. Available from: https://www.healthline.com/nutrition/improve-insulin-sensitivity

14. Ledowsky CJ, Schloss J, Steel A. Variations in folate prescriptions for patients with the MTHFR genetic polymorphisms: a case series study. Explor Res Clin Soc Pharm. 2023 May;10:100277. DOI: 10.1016/j.rcsop.2023.100277

15. Basak S, Mallick R, Duttaroy AK. Maternal docosahexaenoic acid status during pregnancy and its impact on infant neurodevelopment. Nutrients. 2020 Nov;12(12):3615. DOI: 10.3390/nu12123615

16. Dymek A, Oleksy Ł, Stolarczyk A, Bartosiewicz A. Choline-an underappreciated component of a mother-to-be's diet. Nutrients. 2024 Jun;16(11):1767. DOI: 10.3390/nu16111767

17. Obeid R, Derbyshire E, Schön C. Association between maternal choline, fetal brain development, and child neurocognition: systematic review and meta-analysis of human studies. Adv Nutr. 2022 Dec;13(6):2445-2457. DOI: 10.1093/advances/nmac082

18. Sullivan TR, Best KP, Gould J, Zhou SJ, Makrides M, Green TJ. Too much too little: clarifying the relationship between maternal iodine intake and neurodevelopmental outcomes. J Nutr. 2024 Jan;154(1):185-190. DOI: 10.1016/j.tjnut.2023.09.008

19. Levie D, Korevaar TIM, Bath SC, Murcia M, Dineva M, Llop S, et al. Association of maternal iodine status with child IQ: a meta-analysis of individual participant data. J Clin Endocrinol Metab. 2019 Dec;104(12):5957-5967. DOI: 10.1210/jc.2018-02559

20. Zhou SJ, Condo D, Ryan P, Skeaff SA, Howell S, Anderson PJ, et al. Association between maternal iodine intake in pregnancy and childhood neurodevelopment at age 18 months. Am J Epidemiol. 2019 Feb;188(2):332-328. DOI: 10.1093/aje/kwy225

21. Zych-Krekora K, Sylwestrzak O, Krekora M. the critical role of iron in pregnancy, puerperium, and fetal development. J Clin Med. 2025 May;14(10):3482. DOI: 10.3390/jcm14103482

22. Saadh MJ, Sabah Ghnim Z, Salih Mahdi M, Baldaniya L, Karim SA, Srivastava M, et al. The effect of omega-3 supplementation on metabolic, inflammatory and oxidative stress biomarkers in pregnant women: a systematic review and meta-analysis. Front Nutr. 2025 Sep;12:1639906. DOI: 10.3389/fnut.2025.1639906

23. Stanhiser J, Jukic AMZ, McConnaughey DR, Steiner AZ. Omega-3 fatty acid supplementation and fecundability. Hum Reprod. 2022 May;37(5):1037-1046. DOI: 10.1093/humrep/deac027

24. Middleton P, Gomersall JC, Gould JF, Shepherd E, Olsen SF, Makrides M. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst Rev. 2018 Nov;11(11):CD003402. DOI: 10.1002/14651858.CD003402.pub3

25. Patki A, Kar S, Patel N, Ingale K, Bansal K, Durga P. Expert opinion: place in therapy of probiotics in infertility and recurrent implantation failure. Cureus. 2025 Mar;17(3):e81067. DOI: 10.7759/cureus.81067

26. Kamrani A, Asghari KM, Zafarani Y, Rahmanzad F, Soltani-Zangbar MS, Badihi E, et al. The role of probiotics in restoring the Th1 to Th2 ratio in women experiencing recurrent implantation failure; a double-blind randomized clinical trial. Hum Immunol. 2025 Jan;86(1):111220. DOI: 10.1016/j.humimm.2024.111220

27. Rago R, Marcucci I, Leto G, Caponecchia L, Salacone P, Bonanni P, et al. Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: a pilot study. J Biol Regul Homeost Agents. 2015;29(4):913-923.

28. Canosa S, Paschero C, Carosso A, Leoncini S, Mercaldo N, Gennarelli G, et al. Effect of a combination of myo-inositol, alpha-lipoic acid, and folic acid on oocyte morphology and embryo morphokinetics in non-PCOS overweight/obese patients undergoing IVF: a pilot, prospective, randomized study. J Clin Med. 2020 Sep;9(9):2949. DOI: 10.3390/jcm9092949

29. Novielli C, Anelli GM, Lisso F, Marzorati A, Parrilla B, Oneta M, et al. Effects of α-lipoic acid and myo-inositol supplementation on the oocyte environment of infertile obese women: a preliminary study. Reprod Biol. 2020 Dec;20(4):541-546. DOI: 10.1016/j.repbio.2020.10.002

30. Jannatifar R, Piroozmanesh H, Sahraei SS, Asa E. Combination of alpha lipoic acid and metformin supplement improve assisted reproductive technologies outcomes in polycystic ovary syndrome patients. Anat Cell Biol. 2022 Jun;55(2):239-246. DOI: 10.5115/acb.21.242

31. Porcaro G, Brillo E, Giardina I, Di Iorio R. Alpha lipoic acid (ALA) effects on subchorionic hematoma: preliminary clinical results. Eur Rev Med Pharmacol Sci. 2015 Sep;19(18):3426-3432.

32. Bone K, Hywood A. MediHerb unplugged [live stream]. Eight Mile Plains: Integria; 2025 [2026 Feb 20]. Available from: https://practitioner.integria.com/events/mediherb-unplugged

33. Porcaro G, Laganà AS, Neri I, Aragona C. The association of high-molecular-weight hyaluronic acid (HMWHA), alpha lipoic acid (ALA), magnesium, vitamin B6, and vitamin D improves subchorionic hematoma resorption in women with threatened miscarriage: a pilot clinical study. J Clin Med 2024;13(3):706. DOI: 10.3390/jcm13030706

34. Di Tucci C, Di Feliciantonio M, Vena F, Capone C, Schiavi MC, Pietrangeli D, et al. Alpha lipoic acid in obstetrics and gynecology. Gynecol Endocrinol. 2018 Sep;34(9):729-733. DOI: 10.1080/09513590.2018.1462320

35. Monastra G, De Grazia S, Micili SC, Goker A, Unfer V. Immunomodulatory activities of alpha lipoic acid with a special focus on its efficacy in preventing miscarriage. Expert Opin Drug Deliv. 2016 Dec;13(12):1695-1708. DOI: 10.1080/17425247.2016.1200556

36. Halabi Z, El Helou C, Al Balushi H, Gittinger M, Steck AR, Kaakour A, et al. Alpha lipoic acid toxicity: the first reported mortality in an adult patient after multiorgan failure. J Emerg Med. 2023 Feb;64(2):19194. DOI: 10.1016/j.jemermed.2022.12.016

37. Polat S, Kılıçaslan Ö, Sönmez FT. Alpha-lipoic acid intoxication in an adolescent girl: case report and review of the literature. Turk Pediatri Ars. 2020 Sep;55(3):328-330. DOI: 10.14744/TurkPediatriArs.2019.66564

38. Emir DF, Ozturan IU, Yilmaz S. Alpha lipoic acid intoxication: an adult. Am J Emerg Med. 2018 Jun;36(6):1125.e3-1125.e5. DOI: 10.1016/j.ajem.2018.03.022

39. Tolunay O, Çelik T, Kömür M, Gezgin AE, Kaya MS, Çelik Ü. A rare cause of status epilepticus; alpha lipoic acid intoxication, case report and review of the literature. Eur J Paediatr Neurol. 2015 Nov;19(6):730-732. DOI: 10.1016/j.ejpn.2015.07.002

40. Hadzik B, Grass H, Mayatepek E, Daldrup T, Hoehn T. Fatal non-accidental alpha-lipoic acid intoxication in an adolescent girl. Klin Padiatr. 2014 Sep;226(5):292-294. DOI: 10.1055/s-0034-1372622

41. Sehgal T, Ohri U, Mittal N, Attri P, Dishant F. A case of insulin autoimmune syndrome in an Indian male taking alpha-lipoic acid. Cureus 2023;15(8):e43743. DOI: 10.7759/cureus.43743

42. EFSA NDA Panel (EFSA Panel on Nutrition, Novel Foods and Food Allergens), Turck D, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Kearney J, et al. Scientific opinion on the relationship between intake of alpha-lipoic acid (thioctic acid) and the risk of insulin autoimmune syndrome. EFSA J. 2021;19(6):e6577. DOI: 10.2903/j.efsa.2021.6577

43. Cappellani D, Macchia E, Falorni A, Marchetti P. Insulin autoimmune syndrome (Hirata disease): a comprehensive review fifty years after its first description. Diabetes Metab Syndr Obes. 2020;13:963-978. DOI: 10.2147/DMSO.S219438

44. Yukina M, Nuralieva N, Solovyev M, Troshina E, Vasilyev E. Insulin autoimmune syndrome. Endocrinol Diabetes Metab Case Rep. 2020;2020:19-0159. DOI: 10.1530/EDM-19-0159

45. Moffa S, Improta I, Rocchetti S, Mezza T, Giaccari A. Potential cause-effect relationship between insulin autoimmune syndrome and alpha lipoic acid: two case reports. Nutrition. 2019 Jan;57:1-4. DOI: 10.1016/j.nut.2018.04.010

46. Izzo V, Greco C, Corradini D, Infante M, Staltari MT, Romano M, et al. Insulin autoimmune syndrome in an Argentine woman taking a-lipoic acid: a case report and review of the literature. SAGE Open Med Case Rep. 2018;6:2050313X18819601. DOI: 10.1177/2050313X18819601

47. Cappellani D, Sardella C, Campopiano MC, Falorni A, Marchetti P, Macchia E. Spontaneously remitting insulin autoimmune syndrome in a patient taking alpha-lipoic acid. Endocrinol Diabetes Metab Case Rep. 2018:2018:18-0122. DOI: 10.1530/EDM-18-0122

48. Gullo D, Evans JL, Sortino G, Goldfine ID, Vigneri R. Insulin autoimmune syndrome (Hirata disease) in European caucasians taking α-lipoic acid. Clin Endocrinol (Oxf). 2014 Aug;81(2):204-209. DOI: 10.1111/cen.12334

49. Furukawa N, Miyamura N, Nishida K, Motoshima H, Taketa K, Araki E. Possible relevance of alpha lipoic acid contained in a health supplement in a case of insulin autoimmune syndrome. Diabetes Res Clin Pract. 2007 Mar;75(3):366-367. DOI: 10.1016/j.diabres.2006.07.005

50. Bone K, Mills S. Principles and practice of phytotherapy: modern herbal medicine. 2nd ed. London; Churchill Livingstone. 2013.

51. Cahill DJ, Fox R, Wardle PG, Harlow CR. Multiple follicular development associated with herbal medicine. Hum Reprod. 1994 Aug;9(8):1469-1470. DOI: 10.1093/oxfordjournals.humrep.a138731

52. American College of Healthcare Sciences (ACHS). CEU Advanced Herbal Materia Medica American College of Healthcare Sciences: Vitex agnus-castus [Internet]. Portland: ACHS; 2011 [cited 2022 Nov 2]. Available from: https://files.achs.edu/mediabank/files/achsvitexmonographdownload2011.pdf

53. Adebisi OY, Singh M, Tobler KJ. Female infertility [Internet]. Treasure Island: StatPearls; 2025 [cited 2026 Feb 20]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK556033/

54. Rooney KL, Domar AD. The relationship between stress and infertility. Dialogues Clin Neurosci. 2018 Mar;20(1):41-47. DOI: 10.31887/DCNS.2018.20.1/klrooney

55. Buchanan JF, Davis LJ. Drug-induced infertility. Drug Intell Clin Pharm. 1984 Feb;18(2):122-132. DOI: 10.1177/106002808401800205